Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Author
Log in
Sign up
NM
Niels Moya
Author with expertise in Diagnosis and Treatment of Multiple Myeloma
Achievements
This user has not unlocked any achievements yet.
Key Stats
Upvotes received:
0
Publications:
8
(0% Open Access)
Cited by:
1
h-index:
7
/
i10-index:
3
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Overview
Publications
8
Peer Reviews
Comments
Grants
Publications
0
CT-198 Pooled Fecal Allogeneic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Early Access Program in Europe
Florent Malard
et al.
Aug 26, 2024
Ecology
Oncology
0
Paper
Ecology
1
0
Save
0
CAR T-cells in very elderly (≥80 years) lymphoma patients: a DESCAR-T analysis
Simon Menez
et al.
Aug 13, 2024
Oncology
Molecular Biology
0
Paper
Oncology
Molecular Biology
0
Save
0
Pooled Fecal Allogeneic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Early Access Program in Europe
Florent Malard
et al.
Sep 1, 2024
Ecology
Oncology
0
Paper
Ecology
Oncology
0
Save
0
Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-
Versus
-Host Disease : Results from Early Access Program in Europe
Florent Malard
et al.
Nov 5, 2024
Oncology
Microbiology
0
Paper
Oncology
Microbiology
0
Save
0
Prognostic Value of Positron Emission Tomography/Computed Tomography in Multiple Myeloma Patients Treated with Ide-Cel CAR-T Cell Therapy: Preliminary Results of a Real-World IFM Study from the Descar-T Registry (CAR MY PET)
Bertrand Arnulf
et al.
Nov 5, 2024
Oncology
Internal Medicine
0
Paper
Oncology
Internal Medicine
0
Save
0
NK Cells and KIR+ / NKG2A+ Innate like CD8+ T Lymphocytes Features in the Bone Marrow of Multiple Myeloma Patients
Hélène Gardeney
et al.
Nov 5, 2024
Biochemistry
Oncology
0
Paper
Biochemistry
Oncology
0
Save
0
Oral Azacitidine Maintenance after Front-Line Treatment with Azacitidine and Venetoclax in Elderly AML Patients. Single Center Experience
Hélène Gardeney
et al.
Nov 5, 2024
Biochemistry
Oncology
0
Paper
Biochemistry
Oncology
0
Save
0
The Combination of Isatuximab with Pomalidomide and Dexamethasone in Second Line Relapse and Refractory Multiple Myeloma
Arthur Bobin
et al.
Nov 5, 2024
Oncology
Molecular Biology
0
Paper
Oncology
Molecular Biology
0
Save